Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 CyberDEX CyberDEX +19.21%
#5 iExec RLC iExec RLC +18.52%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Classifica tra le azioni #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Prezzo delle azioni
$0.4
Ultima sincronizzazione: 2026-10-02
Capitalizzazione di mercato
$27.18M
Variazione (1 giorno)
-14.88%
Variazione (1 anno)
8.11%
Paese
US
Scambia Cell Source, Inc. (CLCS)

Categoria

Healthcare
Rapporto P/B per Cell Source, Inc. (CLCS)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cell Source, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Cell Source, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5558 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 11.2791 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 4.0142 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.082 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH